Disc Medicine

Disc Medicine, Inc. was founded in 2017 by venture capital firm Atlas Venture and Brian MacDonald, and is headquartered in Massachusetts, USA. It is an early-stage biotechnology company dedicated to developing innovative therapies for hematological disorders. The company’s team possesses expertise in human genetics, biology, and related fields, primarily leveraging hepcidin to promote red blood cell production and help patients with hereditary and acquired anemia regain health.